Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1980 1
1981 3
1983 2
1984 3
1985 2
1986 4
1987 4
1988 3
1989 7
1990 8
1991 4
1993 1
1994 6
1995 4
1996 2
1997 9
1998 15
1999 13
2000 15
2001 18
2002 30
2003 36
2004 22
2005 27
2006 43
2007 57
2008 62
2009 102
2010 99
2011 115
2012 131
2013 173
2014 207
2015 224
2016 207
2017 248
2018 251
2019 246
2020 291
2021 334
2022 411
2023 432
2024 491
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,906 results

Results by year

Filters applied: . Clear all
Page 1
Consensus for HER2 alterations testing in non-small-cell lung cancer.
Ren S, Wang J, Ying J, Mitsudomi T, Lee DH, Wang Z, Chu Q, Mack PC, Cheng Y, Duan J, Fan Y, Han B, Hui Z, Liu A, Liu J, Lu Y, Ma Z, Shi M, Shu Y, Song Q, Song X, Song Y, Wang C, Wang X, Wang Z, Xu Y, Yao Y, Zhang L, Zhao M, Zhu B, Zhang J, Zhou C, Hirsch FR. Ren S, et al. Among authors: shu y. ESMO Open. 2022 Feb;7(1):100395. doi: 10.1016/j.esmoop.2022.100395. Epub 2022 Feb 8. ESMO Open. 2022. PMID: 35149428 Free PMC article. Review.
Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer.
Ding Z, Li Q, Zhang R, Xie L, Shu Y, Gao S, Wang P, Su X, Qin Y, Wang Y, Fang J, Zhu Z, Xia X, Wei G, Wang H, Qian H, Guo X, Gao Z, Wang Y, Wei Y, Xu Q, Xu H, Yang L. Ding Z, et al. Among authors: shu y. Signal Transduct Target Ther. 2021 Jan 20;6(1):26. doi: 10.1038/s41392-020-00448-5. Signal Transduct Target Ther. 2021. PMID: 33473101 Free PMC article. Clinical Trial.
Characterizing dedifferentiation of thyroid cancer by integrated analysis.
Luo H, Xia X, Kim GD, Liu Y, Xue Z, Zhang L, Shu Y, Yang T, Chen Y, Zhang S, Chen H, Zhang W, Li R, Tang H, Dong B, Fu X, Cheng W, Zhang W, Yang L, Peng Y, Dai L, Hu H, Jiang Y, Gong C, Hu Y, Zhu J, Li Z, Caulin C, Wei T, Park J, Xu H. Luo H, et al. Among authors: shu y. Sci Adv. 2021 Jul 28;7(31):eabf3657. doi: 10.1126/sciadv.abf3657. Print 2021 Jul. Sci Adv. 2021. PMID: 34321197 Free PMC article.
Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study.
Huang J, Xu J, Chen Y, Zhuang W, Zhang Y, Chen Z, Chen J, Zhang H, Niu Z, Fan Q, Lin L, Gu K, Liu Y, Ba Y, Miao Z, Jiang X, Zeng M, Chen J, Fu Z, Gan L, Wang J, Zhan X, Liu T, Li Z, Shen L, Shu Y, Zhang T, Yang Q, Zou J; ESCORT Study Group. Huang J, et al. Among authors: shu y. Lancet Oncol. 2020 Jun;21(6):832-842. doi: 10.1016/S1470-2045(20)30110-8. Epub 2020 May 13. Lancet Oncol. 2020. PMID: 32416073 Clinical Trial.
Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer.
Xu J, Wan R, Cai Y, Cai S, Wu L, Li B, Duan J, Cheng Y, Li X, Wang X, Han L, Wu X, Fan Y, Yu Y, Lv D, Shi J, Huang J, Zhou S, Han B, Sun G, Guo Q, Ji Y, Zhu X, Hu S, Zhang W, Wang Q, Jia Y, Wang Z, Song Y, Wu J, Shi M, Li X, Han Z, Liu Y, Yu Z, Liu AW, Wang X, Zhou C, Zhong D, Miao L, Zhang Z, Zhao H, Yang J, Wang D, Wang Y, Li Q, Zhang X, Ji M, Yang Z, Cui J, Gao B, Wang B, Liu H, Nie L, He M, Jin S, Gu W, Shu Y, Zhou T, Feng J, Yang X, Huang C, Zhu B, Yao Y, Yu J, Yao S, Shen R, Wang Z, Wang J. Xu J, et al. Among authors: shu y. Cancer Cell. 2024 Sep 9;42(9):1598-1613.e4. doi: 10.1016/j.ccell.2024.08.013. Cancer Cell. 2024. PMID: 39255777 Free article.
Epigenetic perspectives on cancer chemotherapy response.
Liu MZ, McLeod HL, He FZ, Chen XP, Zhou HH, Shu Y, Zhang W. Liu MZ, et al. Among authors: shu y. Pharmacogenomics. 2014 Apr;15(5):699-715. doi: 10.2217/pgs.14.41. Pharmacogenomics. 2014. PMID: 24798726 Review.
Factors influencing the immunogenicity of influenza vaccines.
Wen S, Wu Z, Zhong S, Li M, Shu Y. Wen S, et al. Among authors: shu y. Hum Vaccin Immunother. 2021 Aug 3;17(8):2706-2718. doi: 10.1080/21645515.2021.1875761. Epub 2021 Mar 11. Hum Vaccin Immunother. 2021. PMID: 33705263 Free PMC article. Review.
3,906 results